Artec NV (Artec NV) EV-to-EBIT : (As of Apr. 26, 2024)

View and export this data going back to 2004. Start your Free Trial

What is Artec NV EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Artec NV's Enterprise Value is $0.00 Mil. Artec NV does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Artec NV's EV-to-EBIT at this moment.

The historical rank and industry rank for Artec NV's EV-to-EBIT or its related term are showing as below:

ATKJ's EV-to-EBIT is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 17.125
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Artec NV's Enterprise Value for the quarter that ended in . 20 was $0.00 Mil. Artec NV does not have enough years/quarters to calculate its EBIT for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate Artec NV's Earnings Yield (Joel Greenblatt) % at this moment.

Artec NV EV-to-EBIT Historical Data

The historical data trend for Artec NV's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artec NV EV-to-EBIT Chart

Artec NV Annual Data

Trend

EV-to-EBIT

Artec NV Quarterly Data

EV-to-EBIT

Competitive Comparison of Artec NV's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Artec NV's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Artec NV's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Artec NV's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Artec NV's EV-to-EBIT falls into.

Artec NV EV-to-EBIT Calculation

Artec NV's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	0.000	/
	=

Artec NV (GREY:ATKJ) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Artec NV's Earnings Yield (Joel Greenblatt) % for the quarter that ended in . 20 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: . 20 )	=	EBIT	/	Enterprise Value (Q: . 20 )
	=		/
	=	%

Artec NV EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Artec NV's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Artec NV (Artec NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Artec Inc NV (GREY:ATKJ) » Definitions » EV-to-EBIT

Traded in Other Exchanges

N/A

Address

5960 South Rampart Drive, Suite 255, Sacramento, CA, USA, 95822

Website

http://www.artec-inc.net

Artec Inc NV is seeking to manufacture, distribute, and market TUBERCIN in the United States and Canada. The Company's product strengthens the immune system to eradicate various types of cancer in patients without any side effects.

Artec NV (Artec NV) Headlines

No Headlines